Skip to main content
MyPeptideMatch
Reviewed by MyPeptideMatch Editorial TeamLast reviewed October 2026Updated October 2026

Cartalax Dosing Protocol: 20 mg Vial — Cartilage & Bone Bioregulator Guide

Cartalax (Ala-Glu-Asp tripeptide) cartilage bioregulator: community-reported dosing, reconstitution math, and what the research does and doesn't support.

Quickstart highlights

Cartalax is the synthetic tripeptide Ala-Glu-Asp (AED, coded T-31 in some studies), developed by Vladimir Khavinson's group in St.

  • No human dose has been established. Every amount on this page is community-reported, not from a trial.
  • Amounts quoted online range from about 200 µg to 10 mg a day; 2–5 mg once daily is a commonly discussed range.
  • For the 2–5 mg range: 20 mg vial + 3 mL bac water = about 6.67 mg/mL, so 2 mg = 30 units and 5 mg = 75 units.
  • At 2–5 mg a day, one 20 mg vial lasts 4 to 10 days; the 12-week schedule below uses about 15 vials.
  • The research behind Cartalax is cell-culture and rat work. See the Cartalax peptide page for the evidence.

Dosing table

For educational reference only. Your prescribing provider may adjust doses based on your clinical profile and response.

WeekDose (µg)UnitsFrequencyNotes
1–3200030Once dailyCommunity-reported starting amount, not from a trial; one 20 mg vial lasts 10 days
4–6300045Once dailyCommunity-reported; one 20 mg vial lasts about 6–7 days
7–9400060Once dailyCommunity-reported; one 20 mg vial lasts 5 days
10–12500075Once dailyCommunity-reported upper end of the commonly discussed range; one 20 mg vial lasts 4 days

Your free Cartalax tracker

  • Dose reminders
  • Injection logging
  • Cycle progress
Create free account Already have one? Sign in

Reconstitution steps

  1. Add 3 mL bacteriostatic water to the 20 mg vial, running it slowly down the vial wall.
  2. Swirl gently until dissolved; do not shake.
  3. Final concentration: about 6.67 mg/mL. On a U-100 insulin syringe, 2 mg = 30 units, 3 mg = 45 units, 4 mg = 60 units and 5 mg = 75 units.
  4. For amounts under 1 mg (such as the 200 µg figure some sources quote), add more water instead: 20 mg + 10 mL gives 2 mg/mL, where 200 µg = 10 units.
  5. Label with the date; refrigerate at 2–8 °C and use within 28 days.

Supplies needed

12-week plan

  • 15 vials
  • 84 syringes
  • 45 mL bac water
  • 84 alcohol swabs
Need clinics? See vetted providers →

Protocol overview & cycle notes

Reference schedule and reconstitution math for a 20 mg Cartalax vial. Cartalax has cell-culture research on aging cartilage cells but no human trials, so every dose on this page is community-reported, not clinically established.

Off-cycle: Not established. Community sources describe breaks of weeks to months between courses; no study has tested cycle length.

Storage & handling

Lyophilized: store below 25 °C, away from light. Reconstituted: refrigerate at 2–8 °C and use within 28 days.

Injection & tracking tips

  • Community protocols describe subcutaneous injection into abdominal or thigh fat; no study has compared routes or timing.
  • Rotate injection sites and use a new sterile syringe every time.
  • No study has tested Cartalax combined with BPC-157, TB-500 or any other peptide, so combination protocols are untested.
  • Cartalax has no human safety data. If you have a joint condition, keep your physician involved.

Tracking

Logging helps you and your provider spot patterns and adjust dose or timing.

  • WOMAC osteoarthritis index every 4 weeks for joint pain and function assessment.
  • Track pain numeric rating scale (NRS 0–10) for target joint daily.
  • MRI or ultrasound of target joint at baseline and 6 months for structural assessment if available.
Log your cycle in the calculator →

How this works & references

Cartalax is the synthetic tripeptide Ala-Glu-Asp (AED, coded T-31 in some studies), developed by Vladimir Khavinson's group in St. Petersburg as a cartilage "bioregulator." In cell-culture studies, AED lowered aging and inflammation markers (p16, p21, p53, TNF-α, IL-1α) in aging chondrocytes and increased cartilage proteins (SOX9, aggrecan, type II collagen, COMP) in aging stem cells. There are no published human trials, and most of the research comes from Khavinson's group without independent replication.

Frequently asked questions

What is the Cartalax dosage?
There is no established Cartalax dosage, because no human trial has tested one. Community-reported schedules for the injectable 20 mg vial run from about 200 µg to 10 mg a day. A commonly discussed schedule starts at 2 mg once daily and rises to 5 mg over 12 weeks. Treat all of these as unverified.
Why do Cartalax doses vary so much online?
Because nobody has done dose-finding research. Oral Cartalax capsules are labeled at about 0.1 mg per capsule while injectable vials hold 20–25 mg, and schedules for the two products often get mixed together. The roughly 50-fold spread between quoted amounts reflects that.
How does Cartalax differ from BPC-157 for joints?
BPC-157 is a 15-amino-acid peptide studied mostly in rodent injury models of tendon and soft-tissue repair. Cartalax is a 3-amino-acid peptide studied mostly in cell cultures of aging cartilage cells. Neither is FDA-approved, and they have never been tested together.
Can Cartalax reverse osteoarthritis?
There is no evidence that it can. No study has tested Cartalax in people with osteoarthritis. Cell studies show effects on aging cartilage cells in a dish, which is a long way from rebuilding cartilage in a joint.
How long does Cartalax take to work?
Unknown. Claims of improvement within a few weeks come from community reports, not from published studies.

Related protocols

This content is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any peptide therapy. Dosing and protocols may vary by formulation and prescriber.